Related Experiment Video
Updated: Jun 8, 2026
10:28
Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
Published on: July 24, 2019
Problems associated with fluid biomarkers for Parkinson's disease
Jakob Nyhlén1, Radu Constantinescu, Henrik Zetterberg
1Institute of Neuroscience & Physiology, Department of Psychiatry & Neurochemistry, Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.
Biomarkers in Medicine
|October 16, 2010
Summary
Diagnosing Parkinson's disease (PD) remains challenging, as no definitive fluid biomarker has been identified. Current research explores promising candidates for early detection and patient stratification, though further validation is needed.
Area of Science:
- Neurology
- Biochemistry
- Biomarker Discovery
Background:
- Parkinson's disease (PD) diagnosis relies on clinical symptoms, often appearing late.
- Objective: To review current biochemical fluid biomarkers for PD diagnostics, early detection, and patient stratification.
Purpose of the Study:
- To provide an updated overview of candidate fluid biomarkers for Parkinson's disease.
- To evaluate the diagnostic performance and limitations of existing biomarkers.
- To discuss challenges and future directions in PD biomarker research.
Main Methods:
- Literature review of current research on Parkinson's disease fluid biomarkers.
- Analysis of diagnostic performance and limitations of candidate biomarkers.
- Discussion of general challenges and potential future strategies.
Main Results:
- No single fluid biomarker currently offers definitive diagnostic utility for Parkinson's disease.
- Several candidate biomarkers show potential but require further investigation.
- Combined analysis of biomarkers may improve diagnostic accuracy in the future.
Conclusions:
- A definitive fluid biomarker for Parkinson's disease diagnosis is still lacking.
- Promising candidates exist and may become valuable tools, potentially in combination.
- Further research is essential to overcome current limitations and advance PD diagnostics.
Related Concept Videos
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:11Alterations in Muscle Tone lll
Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
01:37Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.